Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
12
SHECY Quote, Financials, Valuation and Earnings
Last price:
$16.21
Seasonality move
:
3.3%
Day range:
$15.49 - $16.39
52-week range:
$15.49 - $23.23
Dividend yield:
2.02%
P/E ratio:
--
P/S ratio:
5.75x
P/B ratio:
4.36x
Volume:
449.7K
Avg. volume:
339.5K
1-year change:
-15.81%
Market cap:
$130.9B
Revenue:
--
EPS (TTM):
--
| Period Ending | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13B | $14.4B | $14.2B | $14.1B | $18.5B | |
| Revenue Growth (YoY) | 13.7% | 10.52% | -1.23% | -0.57% | 30.86% | |
| Cost of Revenues | $8.7B | $9.4B | $9.1B | $9B | $10.7B | |
| Gross Profit | $4.3B | $5B | $5.1B | $5.1B | $7.7B | |
| Gross Profit Margin | 33.19% | 34.76% | 36.01% | 36.32% | 41.84% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.3B | $1.4B | $1.4B | $1.4B | $1.7B | |
| Operating Income | $3B | $3.6B | $3.7B | $3.7B | $6B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.1B | $3.7B | $3.9B | $3.8B | $6.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $634M | $914M | $991.2M | $971.3M | $1.5B | |
| Net Income to Company | $3.1B | $3.7B | $3.9B | $3.8B | $6.2B | |
| Minority Interest in Earnings | -$34.5M | -$43.8M | -$39.2M | -$51.4M | -$221.9M | |
| Net Income to Common Excl Extra Items | $2.4B | $2.8B | $2.9B | $2.8B | $4.5B | |
| Basic EPS (Cont. Ops) | $0.56 | $0.65 | $0.69 | $0.67 | $1.07 | |
| Diluted EPS (Cont. Ops) | $0.56 | $0.65 | $0.69 | $0.67 | $1.07 | |
| Weighted Average Basic Share | $4.3B | $4.3B | $4.2B | $4.2B | $4.2B | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $4.1B | $5B | $5.1B | $5.1B | $7.5B | |
| EBIT | $3.1B | $3.8B | $3.9B | $3.7B | $6B | |
| Revenue (Reported) | $13B | $14.4B | $14.2B | $14.1B | $18.5B | |
| Operating Income (Reported) | $3B | $3.6B | $3.7B | $3.7B | $6B | |
| Operating Income (Adjusted) | $3.1B | $3.8B | $3.9B | $3.7B | $6B | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.6B | $3.6B | $4.8B | $5.3B | |
| Revenue Growth (YoY) | 13.57% | -3.23% | 2.08% | 31.17% | 12.08% | |
| Cost of Revenues | $2.3B | $2.2B | $2.3B | $2.7B | $3B | |
| Gross Profit | $1.3B | $1.3B | $1.3B | $2B | $2.3B | |
| Gross Profit Margin | 36.57% | 37.53% | 36.22% | 42.46% | 43.21% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $323.1M | $342.1M | $353.1M | $427.5M | $381.5M | |
| Operating Income | $1B | $995.1M | $964.2M | $1.6B | $1.9B | |
| Net Interest Expenses | -- | -- | $1.5M | -- | -- | |
| EBT. Incl. Unusual Items | $995.9M | $1B | $965.1M | $1.6B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $244.1M | $272.3M | $252.2M | $410.9M | $450.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$12.9M | -$10.5M | -$13.8M | -$68.9M | -$109.7M | |
| Net Income to Common Excl Extra Items | $739M | $752.4M | $699.1M | $1.2B | $1.3B | |
| Basic EPS (Cont. Ops) | $0.17 | $0.18 | $0.17 | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | $4.3B | $4.2B | $4.2B | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $1B | $995.1M | $966.6M | $1.6B | $1.9B | |
| EBIT | $1B | $995.1M | $966.6M | $1.6B | $1.9B | |
| Revenue (Reported) | $3.7B | $3.6B | $3.6B | $4.8B | $5.3B | |
| Operating Income (Reported) | $1B | $995.1M | $964.2M | $1.6B | $1.9B | |
| Operating Income (Adjusted) | $1B | $995.1M | $966.6M | $1.6B | $1.9B | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.4B | $14.3B | $13.7B | $17.2B | $20.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.3B | $9.3B | $8.8B | $10.2B | $11.7B | |
| Gross Profit | $5.1B | $5.1B | $4.9B | $6.9B | $9.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.3B | $1.4B | $1.4B | $1.6B | $1.7B | |
| Operating Income | $3.8B | $3.7B | $3.5B | $5.3B | $7.6B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.8B | $3.9B | $3.6B | $5.4B | $7.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $713.6M | $972.2M | $903.1M | $1.3B | $1.9B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$45.4M | -$37.5M | -$41.3M | -$160.9M | -$390.5M | |
| Net Income to Common Excl Extra Items | $3B | $2.9B | $2.6B | $3.9B | $5.5B | |
| Basic EPS (Cont. Ops) | $0.71 | $0.69 | $0.63 | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $3.8B | $3.8B | $3.8B | $5.2B | $7.6B | |
| EBIT | $3.8B | $3.8B | $3.8B | $5.2B | $7.6B | |
| Revenue (Reported) | $14.4B | $14.3B | $13.7B | $17.2B | $20.9B | |
| Operating Income (Reported) | $3.8B | $3.7B | $3.5B | $5.3B | $7.6B | |
| Operating Income (Adjusted) | $3.8B | $3.8B | $3.8B | $5.2B | $7.6B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8B | $7.5B | $7.7B | $7.9B | $9.1B | |
| Short Term Investments | $1.9B | $1.9B | $2.3B | $2.6B | $2.6B | |
| Accounts Receivable, Net | $3.1B | $3.1B | $3B | $3.1B | $3.9B | |
| Inventory | $2.7B | $3B | $3.4B | $3.3B | $3.7B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $339.8M | $362.1M | $421.4M | $481M | $612.2M | |
| Total Current Assets | $16B | $15.8B | $16.9B | $17.4B | $20B | |
| Property Plant And Equipment | $8.5B | $8.9B | $10.4B | $10.6B | $10.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $849.9M | $783.5M | $762.1M | $712.3M | $687.2M | |
| Total Assets | $27.3B | $27.4B | $29.9B | $30.6B | $33.2B | |
| Accounts Payable | $1.3B | $1.3B | $1.3B | $1.1B | $1.5B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $349.5M | $400M | $332.2M | $370.1M | $471.6M | |
| Total Current Liabilities | $3.6B | $3.5B | $3.5B | $3.3B | $3.9B | |
| Long-Term Debt | $79.3M | $68.8M | $139.9M | $144.9M | $138.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.6B | $4.6B | $4.7B | $4.5B | $5.1B | |
| Common Stock | $1.1B | $1.1B | $1.1B | $1.1B | $978.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $22.1B | $22.2B | $24.6B | $25.5B | $27.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $576.4M | $593.6M | $637.8M | $647.9M | $818.6M | |
| Total Equity | $22.7B | $22.8B | $25.2B | $26.2B | $28.1B | |
| Total Liabilities and Equity | $27.3B | $27.4B | $29.9B | $30.6B | $33.2B | |
| Cash and Short Terms | $9.9B | $9.4B | $10.1B | $10.5B | $11.8B | |
| Total Debt | $146.1M | $132M | $216.7M | $251.6M | $249.1M | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8B | $7.4B | $7.7B | $8.5B | $10.3B | |
| Short Term Investments | $1.8B | $2.1B | $2.3B | $2.5B | $1.3B | |
| Accounts Receivable, Net | $3.3B | $3.3B | $3.4B | $4B | $4.6B | |
| Inventory | $2.7B | $3.1B | $3.6B | $3.5B | $5B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $385.4M | $313.7M | $496.2M | $606.4M | $619.8M | |
| Total Current Assets | $16.2B | $16.2B | $17.5B | $19.1B | $21.8B | |
| Property Plant And Equipment | $8.8B | $9.7B | $11.3B | $10.9B | $12B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -$25.3M | -$24.2M | -$21.6M | -$20.4M | -$48.7M | |
| Total Assets | $27.6B | $28.5B | $31.5B | $32.7B | $36.4B | |
| Accounts Payable | $1.3B | $1.2B | $1.1B | $1.3B | $1.5B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.6B | $1.6B | $1.5B | $1.6B | $1.8B | |
| Total Current Liabilities | $3.2B | $3.1B | $3B | $3.3B | $3.8B | |
| Long-Term Debt | $77.8M | $124.1M | $138.3M | $168.4M | $144.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.3B | $4.3B | $4.3B | $4.6B | $5.2B | |
| Common Stock | $1.1B | $1.1B | $1.2B | $1B | $910.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $592M | $613.8M | $676.2M | $768.6M | $1.1B | |
| Total Equity | $23.4B | $24.2B | $27.3B | $28.1B | $31.2B | |
| Total Liabilities and Equity | $27.6B | $28.5B | $31.5B | $32.7B | $36.4B | |
| Cash and Short Terms | $9.7B | $9.5B | $10B | $11B | $11.6B | |
| Total Debt | $137M | $199.9M | $242.9M | $242.5M | $253M | |
| Period Ending | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.1B | $3.7B | $3.9B | $3.8B | $6.2B | |
| Depreciation & Amoritzation | $1B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$381.7M | -$78.4M | $103.2M | -$207.7M | -$1.1B | |
| Change in Inventories | -$122.7M | -$443M | -$339.6M | -$36.8M | -$615.5M | |
| Cash From Operations | $3B | $3.6B | $3.8B | $3.8B | $4.9B | |
| Capital Expenditures | $1.5B | $2.1B | $2.5B | $2.2B | $1.8B | |
| Cash Acquisitions | -- | -- | -$18.1M | -- | -$31.6M | |
| Cash From Investing | -$2.1B | -$1.6B | -$3.6B | -$2.4B | -$2.3B | |
| Dividends Paid (Ex Special Dividend) | -$481.1M | -$673.4M | -$804.2M | -$862.4M | -$1.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $18.2M | $460K | $77.1M | $43.2M | $41.7M | |
| Long-Term Debt Repaid | -$7.1M | -$2M | -$6.8M | -$7.5M | -$27.1M | |
| Repurchase of Common Stock | -$270.8K | -$807.1M | -$97.2M | -$100.5M | -$53M | |
| Other Financing Activities | $14.2M | $3.5M | -$48.8M | $24.2M | $28.6M | |
| Cash From Financing | -$451.3M | -$1.5B | -$865.4M | -$859.6M | -$1.1B | |
| Beginning Cash (CF) | $6.6B | $7B | $7.6B | $7B | $7.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $407.7M | $492.5M | -$701.3M | $559.7M | $1.6B | |
| Ending Cash (CF) | $7B | $7.5B | $6.9B | $7.6B | $9B | |
| Levered Free Cash Flow | $1.5B | $1.6B | $1.3B | $1.5B | $3.2B | |
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2010-03-31 | 2011-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $357.8M | $148.8M | |
| Depreciation & Amoritzation | -- | -- | -- | $254.8M | $250.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | $70.4M | $331.8M | |
| Change in Inventories | -- | -- | -- | $14.5M | -$102.9M | |
| Cash From Operations | -- | -- | -- | $736.7M | $682.9M | |
| Capital Expenditures | -- | -- | -- | $286.5M | $266M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$211.7M | -$256.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $15M | $21M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$26.3M | -$51.7M | |
| Repurchase of Common Stock | -- | -- | -- | -$89.2K | -$48.2K | |
| Other Financing Activities | -- | -- | -- | -$2M | -$188.1K | |
| Cash From Financing | -- | -- | -- | -$24.6M | -$21.8M | |
| Beginning Cash (CF) | -- | -- | -- | $2.5B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $12.4M | $5.2M | |
| Additions / Reductions | -- | -- | -- | $500.4M | $404.3M | |
| Ending Cash (CF) | -- | -- | -- | $2.9B | $3.5B | |
| Levered Free Cash Flow | -- | -- | -- | $450.1M | $416.9M | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $1.8B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $1.1B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$345.9M | -- | |
| Change in Inventories | -- | -- | -- | -$13.8M | -- | |
| Cash From Operations | -- | -- | -- | $2.6B | -- | |
| Capital Expenditures | -- | -- | $1.1B | $1.4B | $266M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.5B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$472.5M | -$499.1M | $21M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$37.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$331.4K | -- | |
| Other Financing Activities | -- | -- | -- | -$2.8M | -- | |
| Cash From Financing | -- | -- | -- | -$567.5M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $524.3M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $1.2B | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SHECY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHECY
Sector
P/E ratio
--
15.81x
PEG ratio
--
0.00x
P/B ratio
4.36x
1.20x
Price / LTM sales
5.75x
1.40x
Growth Metrics
SHECY
Sector
Revenue growth
--
0.55%
Earnings growth
--
-0.16%
Revenue (5-year growth)
--
3.85%
Earnings forecast
--
$0.06
Profitability
SHECY
Sector
Profitability FY 2024
--
$261.6K
Return on invested capital
--
2.13%
Return on assets
--
1.47%
Return on equity
--
3.08%
Earnings Date
Last Earnings Date
Jul
25
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
SHECY
Sector
Total cash
--
$3.1M
Short term investments
--
$460.5K
Total assets
--
$27.1M
Long term debt
--
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
